Old Web
English
Sign In
Acemap
>
authorDetail
>
Jean-Francois Pouliot
Jean-Francois Pouliot
Regeneron
Medicine
first line
Internal medicine
Oncology
non-small cell lung cancer (NSCLC)
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
FP04.03 Clinical Benefit of First-Line Cemiplimab in Patients with Locally Advanced NSCLC: Subgroup Analysis from EMPOWER-Lung 1
2021
Journal of Thoracic Oncology
Igor Bondarenko
Ahmet Sezer
Sadettin Kilickap
Mahmut Gumus
Mustafa Ozguroglu
M. Gogishvili
Haci Mehmet Türk
Irfan Cicin
D. Bentsion
O. Gladkov
Philip Clingan
Virote Sriuranpong
Naiyer A. Rizvi
Jennifer McGinniss
Jean-Francois Pouliot
S. Lee
Frank Seebach
I. Lowy
Giuseppe Gullo
P Rietschel
Show All
Source
Cite
Save
Citations (0)
Cemiplimab monotherapy as first-line (1L) treatment of patients with brain metastases from advanced non-small cell lung cancer (NSCLC) with programmed cell death-ligand 1 (PD-L1) ≥ 50%: EMPOWER-Lung 1 subgroup analysis.
2021
Journal of Clinical Oncology
Mustafa Ozguroglu
Ahmet Sezer
Saadettin Kilickap
Mahmut Gumus
Igor Bondarenko
Miranda Gogishvili
Haci Mehmet Türk
Irfan Cicin
Dmitry Bentsion
Oleg Gladkov
Philip Clingan
Virote Sriuranpong
Naiyer A. Rizvi
Jennifer McGinniss
Jean-Francois Pouliot
S. Lee
Frank Seebach
Israel Lowy
Giuseppe Gullo
P Rietschel
Show All
Source
Cite
Save
Citations (0)
Network meta-analysis (NMA) of immuno-oncology (IO) monotherapy as first-line (1L) treatments (txs) for advanced non-small cell lung cancer (NSCLC) with PD-L1 expression ≥50%.
2021
Journal of Clinical Oncology
Nick Freemantle
Yingxin Xu
Florence Wilson
Patricia Guyot
Chieh-I Chen
Sam Keeping
Gerasimos Konidaris
Keith Chan
Andreas Kuznik
Kokuvi Atsou
Emily Glowienka
Lisa Stow
Jean-Francois Pouliot
Giuseppe Gullo
P Rietschel
Naiyer A. Rizvi
Show All
Source
Cite
Save
Citations (0)
1